Opinion|Videos|November 28, 2025
International LDL Thresholds
Panelists discuss how global LDL thresholds below 55 mg/dL influence care and challenge U.S. practice to evolve.
Advertisement
Episodes in this series
Panelists discuss how international guidelines—particularly European ones—have adopted aggressive low-density lipoprotein (LDL) thresholds below 55 mg/dL for high-risk patients. These approaches have driven measurable improvements in cardiovascular outcomes abroad.
The conversation examines whether the US should follow suit, balancing clinical benefit against cost, feasibility, and patient adherence.
Panelists agree that while uniform LDL standards could reduce confusion, US implementation would require payer alignment and system-wide commitment.
Advertisement
Related to this article
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, and quality of life.
ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports fewer flare-ups in bronchiectasis.
Experts at CHEST 2026 urge pulmonologists to keep lung cancer in mind for younger patients who never smoked, to order screening and biomarker testing themselves, and to advocate for patients' access to care.
Phentolamine 0.75% (Ryzumvi) won FDA approval for presbyopia based on the phase 3 VEGA-2 and VEGA-3 trials.
Satralizumab, a first-in-class IL-6 receptor inhibitor, was approved for adults with thyroid eye disease based on the phase 3 SatraGO program.
A higher PNR is associated with lower odds of MASLD and advanced liver fibrosis, but further studies are needed to validate findings.
Speakers at CHEST 2026 walked through the first CHEST guideline for non-CF adult bronchiectasis, including which preventive therapy to start first.
SaTScan detects an acute HCV outbreak cluster in California, showing the potential of automated surveillance, though real-time testing is needed.
Advertisement
Advertisement
Trending on AJMC
1
Patents, Rebates, and a Policy Patchwork Keep Inhalers Costly, Panelists Say
2
Administrative Burden Keeps Clinicians From Bedside: Amy Morris, MD
3
How Flatiron Health’s Network Chief Is Building the Future For (and With) Community Oncology Practices
4
International Panel Agrees on Framework for Tapering Psoriasis Biologics
5